NVSEF - Novartis schedules Sandoz spinoff for October
2023-08-18 08:03:01 ET
More on Novartis
- Novartis: Q2 Beats Expectations, But Still Pricey
- Novartis: Strong Growth And Continued Expansion For KISQALI
- Novartis Buys Chinook: M&A To Drive Future Growth
- Novartis and Ionis in pact for new cardiovascular therapy
- Novartis posts Q2 earnings beat, raises FY23 outlook; board endorses Sandoz spinoff
- Seeking Alpha’s Quant Rating on Novartis
- Earnings data for Novartis
For further details see:
Novartis schedules Sandoz spinoff for October